Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains

This study has been completed.
Sponsor:
Collaborator:
MEDRx Co., Ltd.
Information provided by (Responsible Party):
IL Pharma Inc.
ClinicalTrials.gov Identifier:
NCT01198834
First received: September 9, 2010
Last updated: June 28, 2012
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2011
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: June 28, 2012